Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.7K Buy
19,701
+1,700
+9% +$4.63K 0.02% 129
2025
Q4
$78.5K Sell
18,001
-6,100
-25% -$33K 0.03% 127
2025
Q3
$101K Buy
24,101
+6,100
+34% +$21.7K 0.04% 114
2025
Q2
$51.7K Hold
18,001
0.02% 103
2025
Q1
$48.6K Buy
+18,001
New +$67.5K 0.03% 98

Other funds holding GNLX

5T Wealth's GNLX Position: Q1 2026 in Review

5T Wealth increased its Genelux (GNLX) stake by 9.4% in Q1 2026, buying an estimated $4.63K and bringing the position to 19,701 shares worth $47.7K. The position accounts for 0.02% of the portfolio, ranked #129.

5T Wealth first reported a position in GNLX in Q1 2025 and has held it in 5 quarters since. The position peaked at $101K in Q3 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • 5T Wealth held 19,701 shares of Genelux worth $47.7K as of Q1 2026.
  • 5T Wealth bought 1,700 Genelux shares in Q1 2026, an estimated $4.63K.
  • Genelux made up 0.02% of 5T Wealth's portfolio in Q1 2026, its #129 holding.
  • 5T Wealth first reported a position in Genelux in Q1 2025 and has held it in 5 quarters since.
  • 5T Wealth's Genelux position peaked at $101K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on 5T Wealth's 13F filing for Q1 2026, filed 13 Apr 2026.